Asia Morning: U.S. Stocks Lack Significant Momentum

Market sentiment is supported by reports that drug-makers Johnson & Johnson and AstraZeneca will resume trials of COVID-19 vaccines...

Trading floor 2

On Friday, U.S. stocks closed mixed. The Dow Jones Industrial Average dipped 28 points (-0.10%) to 28335, while the S&P 500 added 11 points (+0.34%) to 3465, and the Nasdaq 100 was up 29 points (+0.25%) to 11692.


Dow Jones Industrial Average (Daily Chart) : Bias Remains Bullish

Sources: GAIN Capital, TradingView


Market sentiment was supported by reports that drug-makers Johnson & Johnson (JNJ +0.11%) and AstraZeneca will resume trials of COVID-19 vaccines. Meanwhile, Gilead Sciences' (GILD +0.20%) drug remdesivir became the first COVID-19 treatment approved by the Food and Drug Administration.

Media (+1.3%), Retailing (+0.96%) and Consumer Durables & Apparel (+0.96%) sectors performed the best, while Semiconductors & Semiconductor Equipment (-1.09%), Automobiles & Components (-0.86%) and Energy (-0.55%) sectors lagged behind. 

Nordstrom (JWN +5.60%) was the top gainer. On the other hand, Intel Corp (INTC -10.58%) plunged after its quarterly results missed expectations. 

European stocks were broadly higher. The Stoxx Europe 600 Index rose 0.62%, Germany's DAX 30 climbed 0.82%, France's CAC 40 jumped 1.20% and the U.K.'s FTSE 100 was up 1.29%.

U.S. Treasury prices ticked up, as the benchmark 10-year Treasury yield edged down to 0.840% from 0.845% Thursday.

Spot gold dipped $1 (-0.08%) to $1,902 an ounce.

U.S. WTI crude futures (December) fell $0.88 (-2.17%) to $39.76 a barrel.

On the forex front, the U.S. dollar resumed its weakness against other major currencies. The ICE Dollar Index dropped 0.20% to 92.76. On a daily chart, the 20-day moving average has crossed below the 50-day one. The Markit U.S. Manufacturing Purchasing Managers Index (PMI) (preliminary reading) edged up to 53.3 in October (53.5 expected). 

EUR/USD rebounded 0.37% to 1.1862. On technical terms, the pair has confirmed a bullish signal of 20-day/ 50-day  moving-average-crossover. The Markit Eurozone Manufacturing PMI (preliminary reading) rose to 54.4 in October (53.0 expected). 

GBP/USD was down for a second day as it slipped 0.33% to 1.3039. U.K. official data showed that retail sales gained 1.5% on month in September (+0.2% expected), while the GfK consumer confidence index fell to -31 in October (-28 expected). The Markit U.K. Manufacturing PMI (preliminary reading) posted at 53.3 for October (53.1 expected).

USD/JPY slipped 0.12% to 104.73. Official data showed that Japan's Consumer Prices were flat on year in September (as expected).

AUD/USD gained 0.32% to 0.7140, while USD/CAD dipped a further 0.09% to 1.3124.


More from Commodities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.